Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

Study ID: NCT07457164
Start Date: 2026-07
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Teverelix DP 180 mg

Sponsor

Antev Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica

Study ID: NCT07448363
Start Date: 2026-05
End Date: 2031-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Abrocitinib

Upadacitinib

Baricitinib

Dupilumab

Sponsor

Costa Rican Social Security Fund

Source: clinicaltrials.gov

Share:
Add to list

Androgenic Alopecia TH07 Clinical Trial

Study ID: NCT07435012
Start Date: 2026-04
End Date: 2028-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

420

Intervention / Treatment

W07

W07

Minoxidil 5% Topical Solution

Placebo

Sponsor

Triple Hair Inc

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MyeloMATCH Treatment Trial)

Study ID: NCT06917911
Start Date: 2026-06-18
End Date: 2027-11-25
Study Type

Interventional

Study Phase

Phase2

No. of Participants

162

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Cytarabine

Daunorubicin Hydrochloride

Echocardiography Test

Gemtuzumab Ozogamicin

Multigated Acquisition Scan

Venetoclax

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Study ID: NCT07195734
Start Date: 2026-10-09
End Date: 2033-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

180

Intervention / Treatment

Biospecimen Collection

Carboplatin

Cemiplimab

Cisplatin

Computed Tomography

Paclitaxel

Positron Emission Tomography

Radiation Therapy

Salvage Surgery

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma

Study ID: NCT07353099
Start Date: 2026-04-30
End Date: 2030-04-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

No Intervention

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

Correlates and Control of Blood Pressure Variability

Study ID: NCT06012487
Start Date: 2026-05-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

10

Intervention / Treatment

Low BPV Regimen

Sponsor

Cedars-Sinai Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Bleeding Management İn Open Heart Surgery

Study ID: NCT07366606
Start Date: 2026-04
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment

Blood Product

Sponsor

Serkan Uckun

Source: clinicaltrials.gov

Share:
Add to list

Influence of Implant Insertion Depth on Peri-implant Bone Changes Around Short Implants

Study ID: NCT07468747
Start Date: 2026-03-30
End Date: 2027-05-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

58

Intervention / Treatment

Subcrestal Dental Implant Placement

Crestal Dental Implant Placement

Sponsor

Gulf Medical University

Source: clinicaltrials.gov

Share:
Add to list

Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer

Study ID: NCT07125209
Start Date: 2026-04
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

18

Intervention / Treatment

Patient Reported Outcomes Assessment

Cognitive and General Health Assessments

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list